Director, Biostatistics: Early-Phase Oncology Leader

Exelixis, Inc.; Alameda (CA); On-site; USD 248,000 - 352,500; Full time

Benefits offered by this job

401k plan with company contributions

Group medical, dental and vision coverage

15 accrued vacation days

Job summary

Exelixis, Inc. is looking for a Sr Director, Biostatistics in Alameda, California. You will lead the biostatistics function, managing a team to develop statistical strategies for clinical trials focusing on early phases.

Your role includes overseeing statistical input on translational medicine and clinical biomarkers. With over 12 years in the field, you'll also be responsible for engaging with FDA regulations and ensuring project success across various clinical studies.

The position offers a competitive salary with performance-based bonuses and comprehensive benefits.

Qualifications

• Minimum 13 years of experience with MS/MA; 12 with PhD.
• 5+ years managing clinical trials in oncology.
• Applicable knowledge of FDA/EMA/ICH guidelines.

Responsibilities

• Oversee statistical support for clinical trials.
• Develop department standards and process improvements.
• Interact with regulatory authorities (FDA/EU).

Skills

Leadership in statistics

Clinical trial management

Communication skills

Conflict management

Statistical analysis

Education

MS/MA in Statistics/Biostatistics

PhD in Statistics/Biostatistics

Tools

Statistical software

CDISC standards

Job description

Exelixis, Inc. is looking for a Sr Director, Biostatistics in Alameda, California. You will lead the biostatistics function, managing a team to develop statistical strategies for clinical trials focusing on early phases.

Your role includes overseeing statistical input on translational medicine and clinical biomarkers. With over 12 years in the field, you'll also be responsible for engaging with FDA regulations and ensuring project success across various clinical studies.

The position offers a competitive salary with performance-based bonuses and comprehensive benefits.